{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-002624","form_type":"8-K","ticker":"SABS","cik":"0001833214","company_name":"SAB Biotherapeutics, Inc.","filed_at":"2023-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.935691+00:00","generated_at":"2026-06-19T23:06:19.235840+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"SAB Biotherapeutics presents DiversitAb platform and clinical data at BIO CEO Conference","bullets":["Presentation highlighted DiversitAb platform and completed trial data showing polyclonal antibody efficacy against mutating pathogens.","No specific financial results or forward guidance were disclosed in the 8-K or presentation summary.","Audio recording and presentation slides made available on Company's IR website prior to conference.","Information furnished under Item 7.01 and not deemed filed for SEC liability purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-002624","json":"https://secwatch.observer/filing/0001437749-23-002624.json","markdown":"https://secwatch.observer/filing/0001437749-23-002624.md","text":"https://secwatch.observer/filing/0001437749-23-002624.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1833214/000143774923002624/0001437749-23-002624-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1833214/000143774923002624/sabs20230206_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T23:06:19.235840+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}